BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, February 9, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 10, 2015
View Archived Issues
Hepatocyte-tageted insulin gene transfer induces tolerance and protects against T1D
Read More
Sacituzumab govitecan shows acceptable safety profile
Read More
Sanofi extends collaboration with Medicines for Malaria Venture
Read More
Immunovaccine and PharmAthene to develop anthrax vaccine formulated in DepoVax
Read More
Novartis develops LTA4H inhibitors
Read More
Purdue Pharma presents Na1.7 channel blockers
Read More
Orion designs BET inhibitors
Read More
Sunshine Lake Pharma reports 5-HT reuptake inhibitors/5-HT1A receptor agonists
Read More
Vaccine candidate LT-69 confers long-term protection against M. tuberculosis infection in mice
Read More
Idarucizumab rapidly and completely reverses anticoagulant effects of dabigatran in clinical trial
Read More
Coretherapix's allogeneic human cardiac stem cells infusion enters phase I/II clinical trial
Read More
Nintedanib shows potent antifibrotic effects in preclinical models of SSc
Read More
Novel BTK inhibitor shows potential for the treatment of RA
Read More
FDA clears phase IIa study of AR-301 in acute pneumonia to expand into U.S.
Read More
Anika Therapeutics reports data from follow-up study of Cingal
Read More
Seattle Genetics begins Adcetris trial in systemic lupus erythematosus
Read More
Sorrento and NantBioScience to develop small molecule therapies against cancer
Read More
FDA grants fast track designation to Toca-511 & Toca-FC for recurrent glioma
Read More
Ultragenyx reports Fast Track designation and 40-week treatment data of KRN-23 in pedriatic XLH
Read More
Lancaster University researchers plan trial of liragutide in ALS
Read More
NIH grant supports Califia Bio's development of CLFB-1134 to treat cognitive deficits in MS
Read More
FDA approves first COPD biomarker
Read More
OWL to develop companion diagnostic for Galmed's Aramchol
Read More
ORIG3N to generate cells for research into Sturge-Weber syndrome
Read More
Aquinox's AQX-1125 fails to show benefit in phase II COPD trial
Read More
Globavir licenses BC-001 to Sorrento Therapeutics
Read More
